Literature DB >> 18253929

Viral danger signals control CD1d de novo synthesis and NKT cell activation.

Martin J Raftery1, Florian Winau, Thomas Giese, Stefan H E Kaufmann, Ulrich E Schaible, Günther Schönrich.   

Abstract

The nonpolymorphic CD1 molecules present lipid antigens to T cells. In myeloid DC humans express five different CD1 proteins (CD1a-e; the corresponding CD1 genes are designated CD1A-E). A role for CD1d-restricted NKT cells in the control of virus infections has been delineated from clinical observations, mouse models and viral evasion mechanisms targeting CD1d. How NKT cells are activated by virus infections is unclear. We found that human myeloid DC differentially regulate CD1 antigen presentation in response to viral danger signals. Stimulation with type I IFN, viral TLR ligands or viruses strongly enhanced the number of CD1D transcripts in human myeloid DC but diminished the abundance of CD1A, CD1B and CD1E mRNA. These changes on the transcriptional level were mirrored by altered cellular distribution and increased surface expression of CD1d. As a consequence NKT cells were activated and showed a Th1-like response. Moreover, NKT cell activation in PBMC exposed to viral danger signals was dependent on human plasmacytoid DC which produce large amounts of IFN-alpha. In conclusion, our data indicate that viral danger signals trigger NKT cell activation by enhancing CD1d de novo synthesis through increasing the abundance of CD1D mRNA in human myeloid DC.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18253929     DOI: 10.1002/eji.200737233

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  23 in total

Review 1.  Turned on by danger: activation of CD1d-restricted invariant natural killer T cells.

Authors:  Victoria Lawson
Journal:  Immunology       Date:  2012-09       Impact factor: 7.397

Review 2.  Lipid antigens in immunity.

Authors:  C Marie Dowds; Sabin-Christin Kornell; Richard S Blumberg; Sebastian Zeissig
Journal:  Biol Chem       Date:  2014-01       Impact factor: 3.915

Review 3.  Endosomal processing for antigen presentation mediated by CD1 and Class I major histocompatibility complex: roads to display or destruction.

Authors:  Marianne Boes; Arie J Stoppelenburg; Fenna C M Sillé
Journal:  Immunology       Date:  2009-06       Impact factor: 7.397

4.  Cutting edge: the mechanism of invariant NKT cell responses to viral danger signals.

Authors:  Aaron J Tyznik; Emmanuel Tupin; Niranjana A Nagarajan; Min J Her; Chris A Benedict; Mitchell Kronenberg
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

5.  Distinct requirements for activation of NKT and NK cells during viral infection.

Authors:  Aaron J Tyznik; Shilpi Verma; Qiao Wang; Mitchell Kronenberg; Chris A Benedict
Journal:  J Immunol       Date:  2014-03-14       Impact factor: 5.422

6.  Severe loss of invariant NKT cells exhibiting anti-HTLV-1 activity in patients with HTLV-1-associated disorders.

Authors:  Kazuko Azakami; Tomoo Sato; Natsumi Araya; Atae Utsunomiya; Ryuji Kubota; Kenshi Suzuki; Daisuke Hasegawa; Toshihiko Izumi; Hidetoshi Fujita; Satoko Aratani; Ryoji Fujii; Naoko Yagishita; Hajime Kamijuku; Takuro Kanekura; Ken-ichiro Seino; Kusuki Nishioka; Toshihiro Nakajima; Yoshihisa Yamano
Journal:  Blood       Date:  2009-08-07       Impact factor: 22.113

7.  Vesicular stomatitis virus matrix protein impairs CD1d-mediated antigen presentation through activation of the p38 MAPK pathway.

Authors:  Gourapura J Renukaradhya; Masood A Khan; Daniel Shaji; Randy R Brutkiewicz
Journal:  J Virol       Date:  2008-09-24       Impact factor: 5.103

8.  Innate-like control of human iNKT cell autoreactivity via the hypervariable CDR3beta loop.

Authors:  Gediminas Matulis; Joseph P Sanderson; Nikolai M Lissin; Maria B Asparuhova; Gopal R Bommineni; Daniel Schümperli; Richard R Schmidt; Peter M Villiger; Bent K Jakobsen; Stephan D Gadola
Journal:  PLoS Biol       Date:  2010-06-22       Impact factor: 8.029

9.  Direct CD1d-mediated stimulation of APC IL-12 production and protective immune response to virus infection in vivo.

Authors:  Simon C Yue; Michael Nowak; Angela Shaulov-Kask; RuoJie Wang; Dominic Yue; Steven P Balk; Mark A Exley
Journal:  J Immunol       Date:  2009-11-30       Impact factor: 5.422

10.  Identification of distinct human invariant natural killer T-cell response phenotypes to alpha-galactosylceramide.

Authors:  Joanne E Croudace; Stuart M Curbishley; Manuela Mura; Carrie R Willcox; Petr A Illarionov; Gurdyal S Besra; David H Adams; David A Lammas
Journal:  BMC Immunol       Date:  2008-12-03       Impact factor: 3.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.